Toregem BioPharma

About:

Toregem BioPharma is a startup from Kyoto University that develops a treatment and tooth regeneration drug for congential adential.

Website: http://www.toregem.co.jp/

Top Investors: Kyoto University Innovation Capital, Future Venture Capital, Kyushin Social Capital, Astellas Venture Management, Kyogin Lease & Capital

Description:

Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.

Total Funding Amount:

890M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kyoto, Kyoto, Japan

Founded Date:

2020-05-01

Contact Email:

info(AT)toregem.co.jp

Founders:

Honoka Kiso, Katsu Takahashi, Muneo Takatani

Number of Employees:

1-10

Last Funding Date:

2023-07-01

IPO Status:

Private

Industries: